✦ LIBER ✦

Paclitaxel beneficial in platinum-sensitive relapsed ovarian cancer

Book ID: 120859482
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313930-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of partially platinum-sensiti

Management of partially platinum-sensitive relapsed ovarian cancer

✍ Stanley B. Kaye 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Olaparib Maintenance Therapy in Platinum

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

✍ Ledermann, Jonathan; Harter, Philipp; Gourley, Charlie; Friedlander, Michael; Ve 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 507 KB

Evaluation of weekly low-dose paclitaxel

Evaluation of weekly low-dose paclitaxel and carboplatin treatment for patients with platinum-sensitive relapsed ovarian cancer

✍ Yoh Watanabe; Hidekatsu Nakai; Haruhiko Ueda; Hiroshi Hoshiai 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Polyglutamate paclitaxel conjugate benef

Polyglutamate paclitaxel conjugate beneficial in recurrent ovarian cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Topotecan in Platinum- and Paclitaxel-Re

Topotecan in Platinum- and Paclitaxel-Resistant Ovarian Cancer

✍ Elizabeth M. Swisher; David G. Mutch; Janet S. Rader; Alaa Elbendary; Thomas J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Farletuzumab (a monoclonal antibody agai

Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer

✍ Armstrong, Deborah K.; White, Allen J.; Weil, Susan C.; Phillips, Martin; Colema 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 412 KB